Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prions

Journal of Molecular Biology

Volumn 402, Issue 2, 2010, Pages 293-300

  Kolodziejczak, Dominika ^a   Da Costa Dias, Bianca ^b   Zuber, Chantal ^a   Jovanovic, Katarina ^b   Omar, Aadilah ^b   Beck, Julia ^c   Vana, Karen ^a   Mbazima, Vusi ^b   Richt, Juergen ^d   Brenig, Bertram ^c   Weiss, Stefan F T ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

CWD; Laminin receptor; Prion; Scrapie; Variant Creutzfeldt Jakob disease

Indexed keywords

LAMININ RECEPTOR; PRION PROTEIN; PRION; PROTEIN BINDING;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN HOMOGENATE; CATTLE; CHRONIC WASTING DISEASE; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTESTINE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRION; PRIORITY JOURNAL; SCRAPIE; SHEEP; TISSUE CULTURE; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS TRANSMISSION; ANIMAL; BOVINAE; BRAIN; CELL LINE; DEER; METABOLISM; PATHOLOGY; PRION DISEASE; PROTEIN ANALYSIS; SWINE; TRANSMISSION; ZOONOSIS;

BOS; BOVINAE; CERVIDAE; OVIS; OVIS ARIES; SUIDAE; SUS;

ANIMALS; BRAIN; CATTLE; CELL LINE; DEER; ENTEROCYTES; HUMANS; PRION DISEASES; PRIONS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECEPTORS, LAMININ; SHEEP; SWINE; ZOONOSES;

EID: 77956763891     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.06.055     Document Type: Article

References (39)

1. Griffith J.S. Self-replication and scrapie. Nature 1967, 215:1043-1044.
2. Prusiner S.B. Scrapie prions. Annu. Rev. Microbiol. 1989, 43:345-374.
3. Wilesmith J.W., Wells G.A., Cranwell M.P., Ryan J.B. Bovine spongiform encephalopathy: epidemiological studies. Vet. Rec. 1988, 123:638-644.
4. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389:498-501.
5. Bruce M., Chree A., McConnell I., Foster J., Pearson G., Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. London Ser. B 1994, 343:405-411.
6. Chesebro B. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 2003, 66:1-20.
7. Prusiner S.B. Molecular biology and genetics of prion diseases. Philos. Trans. R. Soc. London Ser. B 1994, 343:447-463.
8. Pattison I.H. Scrapie in the welsh mountain breed of sheep and its experimental transmission to goats. Vet. Rec. 1965, 77:1388-1390.
9. Wells G.A., Hawkins S.A., Austin A.R., Ryder S.J., Done S.H., Green R.B., et al. Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs. J. Gen. Virol. 2003, 84:1021-1031.
10. Collinge J., Palmer M.S., Sidle K.C., Hill A.F., Gowland I., Meads J., et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 1995, 378:779-783.
11. Scott M.R., Peretz D., Nguyen H.O., Dearmond S.J., Prusiner S.B. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J. Virol. 2005, 79:5259-5271.
12. Heppner F.L., Christ A.D., Klein M.A., Prinz M., Fried M., Kraehenbuhl J.P., Aguzzi A. Transepithelial prion transport by M cells. Nat. Med. 2001, 7:976-977.
13. sc) in the small intestinal epithelial cells of neonatal mice. Vet. Pathol. 2003, 40:723-727.
14. Morel E., Andrieu T., Casagrande F., Gauczynski S., Weiss S., Grassi J., et al. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am. J. Pathol. 2005, 167:1033-1042.
15. Booth C., Potten C.S. Gut instincts: thoughts on intestinal epithelial stem cells. J. Clin. Invest. 2000, 105:1493-1499.
16. c is expressed in human enterocytes in cell-cell junctional domains. J. Biol. Chem. 2004, 279:1499-1505.
17. Mishra R.S., Basu S., Gu Y., Luo X., Zou W.Q., Mishra R., et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J. Neurosci. 2004, 24:11280-11290.
18. Shmakov A.N., Bode J., Kilshaw P.J., Ghosh S. Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins?. J. Pathol. 2000, 191:318-322.
19. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 2001, 20:5863-5875.
20. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., et al. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 2006, 194:702-709.
21. Sc propagation in scrapie infected mice. Prion 2007, 1:207-212.
22. Zuber C., Knackmuss S., Rey C., Reusch U., Rottgen P., Frohlich T., et al. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases. Mol. Immunol. 2008, 45:144-151.
23. Zuber C., Mitteregger G., Schuhmann N., Rey C., Knackmuss S., Rupprecht W., et al. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy. J. Gen. Virol. 2008, 89:2055-2061.
24. Ludewigs H., Zuber C., Vana K., Nikles D., Zerr I., Weiss S. Therapeutic approaches for prion disorders. Expert Rev. Anti-Infect. Ther. 2007, 5:613-630.
25. Zuber C., Ludewigs H., Weiss S. Therapeutic approaches targeting the prion receptor LRP/LR. Vet. Microbiol. 2007, 123:387-393.
26. Vana K., Zuber C., Nikles D., Weiss S. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell. Mol. Neurobiol. 2007, 27:107-128.
27. Vana K., Zuber C., Pflanz H., Kolodziejczak D., Zemora G., Bergmann A.K., Weiss S. LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer. Infect. Disord. Drug Targets 2009, 9:69-80.
28. Kong Q., Huang S., Zou W., Vanegas D., Wang M., Wu D., et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J. Neurosci. 2005, 25:7944-7949.
29. c and other ligands with the 37 kDa/67 kDa laminin receptor. Front. Biosci. 2010, 15:1150-1163.
30. Foster J.D., Hope J., Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet. Rec. 1993, 133:339-341.
31. Foster J.D., Parnham D., Chong A., Goldmann W., Hunter N. Clinical signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats. Vet. Rec. 2001, 148:165-171.
32. Foster J.D., Parnham D.W., Hunter N., Bruce M. Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J. Gen. Virol. 2001, 82:2319-2326.
33. Bellworthy S.J., Dexter G., Stack M., Chaplin M., Hawkins S.A., Simmons M.M., et al. Oral transmission of BSE to VRQ/VRQ sheep in an experimental flock. Vet. Rec. 2008, 162:130-131.
34. Maddison B.C., Rees H.C., Baker C.A., Taema M., Bellworthy S.J., Thorne L., et al. Prions are secreted into the oral cavity in sheep with preclinical scrapie. J. Infect. Dis. 2010, 201:1672-1676.
35. Da Costa Dias B., Weiss S.F. A kiss of a prion: new implications for oral transmissibility. J. Infect. Dis. 2010, 201:1615-1616.
36. Ghosh S. Intestinal entry of prions. Z. Gastroenterol. 2002, 40:37-39.
37. Glaysher B.R., Mabbott N.A. Role of the GALT in scrapie agent neuroinvasion from the intestine. J. Immunol. 2007, 178:3757-3766.
38. res. J. Mol. Biol. 2009, 388:721-729.
39. Pflanz H., Vana K., Mitteregger G., Pace C., Messow D., Sedlaczek C., et al. Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice. J. Gen. Virol. 2009, 90:269-274.